Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Rubina M. Khair"'
Autor:
Catherine E. Simpson, Rachel L. Damico, Laura Hummers, Rubina M. Khair, Todd M. Kolb, Paul M. Hassoun, Stephen C. Mathai
Publikováno v:
Pulmonary Circulation, Vol 9 (2019)
The object of this paper is to assess associations between serum uric acid (UA) and pulmonary arterial hypertension (PAH) risk, disease severity, and mortality in a well-characterized cohort of systemic sclerosis (SSc) patients referred for evaluatio
Externí odkaz:
https://doaj.org/article/481d8af0a9f84c97b12d1c8fcaa09187
Autor:
Paul M. Hassoun, Ryan J. Tedford, Todd M. Kolb, Rubina M. Khair, Tomoki Fujii, Ela Chamera, Steven Hsu, Stefan L. Zimmerman, David A. Kass, Catherine E. Simpson, Ichizo Tsujino, Rachel L. Damico, Stephen C. Mathai, Christopher J Mullin, Bharath Ambale-Venkatesh, Takahiro Sato, Joao A.C. Lima, Celia P. Corona-Villalobos, Valentina Mercurio
Publikováno v:
Pulmonary Circulation
Pulmonary Circulation, Vol 11 (2021)
Pulmonary Circulation, Vol 11 (2021)
Right ventricular function has prognostic significance in patients with pulmonary hypertension. We evaluated whether cardiac magnetic resonance-derived strain and strain rate parameters could reliably reflect right ventricular systolic and diastolic
Autor:
Rachel L. Damico, Rubina M. Khair, Paul M. Hassoun, Laura K. Hummers, Catherine E. Simpson, Stephen C. Mathai, Todd M. Kolb
Publikováno v:
Pulmonary Circulation
Pulmonary Circulation, Vol 9 (2019)
Pulmonary Circulation, Vol 9 (2019)
The object of this paper is to assess associations between serum uric acid (UA) and pulmonary arterial hypertension (PAH) risk, disease severity, and mortality in a well-characterized cohort of systemic sclerosis (SSc) patients referred for evaluatio
Autor:
Rubina M. Khair, Stefan L. Zimmerman, Celia P. Corona-Villalobos, Erica H. Pullins, Reda E. Girgis, Ryan J. Tedford, Todd M. Kolb, Takahiro Sato, Joao A.C. Lima, Stephen C. Mathai, Rachel L. Damico, Paul M. Hassoun, Roham T. Zamanian, Bharath Ambale-Venkatesh, Olivia L. Hulme, Omar A. Minai, Kelly Chin, Tomoki Fujii
Publikováno v:
Pulmonary Circulation, Vol 8 (2018)
Pulmonary Circulation
Pulmonary Circulation
The aim of this study was to evaluate the effect of upfront combination therapy with ambrisentan and tadalafil on left ventricular (LV) and right ventricular (RV) function in patients with systemic sclerosis-associated pulmonary arterial hypertension
Autor:
Todd M. Kolb, Rachel L. Damico, Stefan L. Zimmerman, Stephen C. Mathai, Rubina M. Khair, Catherine E. Simpson, Paul M. Hassoun
Publikováno v:
Pulmonary hypertension.
Background: Right ventricular (RV) dysfunction is the leading cause of mortality in pulmonary arterial hypertension (PAH), and cardiac magnetic resonance (CMR) measures of RV volumes and mass are known to predict mortality in PAH. Ventricular mass in
Autor:
Stephen C. Mathai, Takahiro Sato, Stefan L. Zimmerman, Catherine E. Simpson, Rachel L. Damico, Rubina M. Khair, Paul M. Hassoun, Khalil I. Bourji, Ryan J. Tedford, Todd M. Kolb
Publikováno v:
The European respiratory journal. 53(4)
Increased right ventricular mass and VMI, the ratio of RV mass to LV mass, are predictors of mortality in incident, treatment-naive PAH. These findings challenge the notion that RV hypertrophy is adaptive in pulmonary hypertension.http://ow.ly/qzvt30
Autor:
Monica Mukherjee, Roham T. Zamanian, Reda E. Girgis, Valentina Mercurio, Paul M. Hassoun, Kelly Chin, Stephen C. Mathai, Rubina M. Khair, Takahiro Sato, Ryan J. Tedford, Omar A. Minai, Todd M. Kolb, Rachel L. Damico, Fernando Torres
Publikováno v:
American journal of respiratory and critical care medicine. 197(3)
Autor:
Todd M. Kolb, Chisom Nwaneri, Rubina M. Khair, Rachel L. Damico, Stephen C. Mathai, Paul M. Hassoun
Publikováno v:
Annals of the American Thoracic Society. 13(6)
Despite therapeutic advances, pulmonary arterial hypertension remains a disease without a cure. Focusing on symptoms, such as dyspnea, is an important part of assessing response to therapy.To determine the minimal important differences for the Borg d
Autor:
Rubina M. Khair, Rachel L. Damico, Todd M. Kolb, Tomeka Suber, Stephen C. Mathai, Paul M. Hassoun
Pulmonary arterial hypertension is a progressive disease with high morbidity and mortality despite advances in medical therapy. The relationship between patient-related outcomes, such as health-related quality of life (HRQOL), and survival is not wel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a45881023a88ed76285bdd83a6d36611
https://europepmc.org/articles/PMC4722843/
https://europepmc.org/articles/PMC4722843/
Autor:
Mohamed A. Gashouta, Stephen C. Mathai, Ryan J. Tedford, Olivia L. Hulme, Omar A. Minai, Chiara Pisanello, Todd M. Kolb, Paul M. Hassoun, Rubina M. Khair, Erica H. Pullins, Rachel L. Damico, Fernando Torres, Kelly Chin, Reda E. Girgis, Traci Housten, Takahiro Sato, Noah Lechtzin, Stefan L. Zimmerman, Roham T. Zamanian, Celia P. Corona-Villalobos
Publikováno v:
American journal of respiratory and critical care medicine. 192(9)
Scleroderma-associated pulmonary arterial hypertension (SSc-PAH) is a rare disease characterized by a very dismal response to therapy and poor survival. We assessed the effects of up-front combination PAH therapy in patients with SSc-PAH.In this pros